Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Holinstat

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
Molecular Pharmacology|February 17, 2007
PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axisBryan Voss, Joseph N McLaughlin, Michael Holinstat, et al.
Molecular Pharmaceutics|January 31, 2025
Antiplatelet Effects of DMPC-Based Synthetic High-Density Lipoproteins: Exploring Particle Structure and Noncholesterol Efflux MechanismsAntonela Rodriguez, Minzhi Yu, May Thazin Phoo, et al.
The Journal of Biological Chemistry|May 20, 2003
Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangementMichael Holinstat, Dolly Mehta, Tohru Kozasa, et al.
European Journal of Pharmacology|March 5, 2021
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19Bertram Pitt, Nadia R Sutton, Zhong Wang, et al.
Science Advances|December 5, 2020
Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in miceHongliang He, Reheman Adili, Lisha Liu, et al.
The Journal of Physiology|March 19, 2002
Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier functionDolly Mehta, Chinnaswamy Tiruppathi, Raudal Sandoval, et al.
The Journal of Biological Chemistry|November 26, 2005
Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeabilityMichael Holinstat, Nebojsa Knezevic, Michael Broman, et al.
Biochemistry|May 24, 2021
<i>In Vitro</i> Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2Wan-Chen Tsai, Chakrapani Kalyanaraman, Adriana Yamaguchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2014
Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axisBenjamin E Tourdot, Stanley Conaway, Katrin Niisuke, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 28, 2021
Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in MiceReheman Adili, Madeline Jackson, Livia Stanger, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Molecular Pharmacology|February 17, 2007
PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axisBryan Voss, Joseph N McLaughlin, Michael Holinstat, et al.
Molecular Pharmaceutics|January 31, 2025
Antiplatelet Effects of DMPC-Based Synthetic High-Density Lipoproteins: Exploring Particle Structure and Noncholesterol Efflux MechanismsAntonela Rodriguez, Minzhi Yu, May Thazin Phoo, et al.
The Journal of Biological Chemistry|May 20, 2003
Protein kinase Calpha-induced p115RhoGEF phosphorylation signals endothelial cytoskeletal rearrangementMichael Holinstat, Dolly Mehta, Tohru Kozasa, et al.
European Journal of Pharmacology|March 5, 2021
Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19Bertram Pitt, Nadia R Sutton, Zhong Wang, et al.
Science Advances|December 5, 2020
Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in miceHongliang He, Reheman Adili, Lisha Liu, et al.
The Journal of Physiology|March 19, 2002
Modulatory role of focal adhesion kinase in regulating human pulmonary arterial endothelial barrier functionDolly Mehta, Chinnaswamy Tiruppathi, Raudal Sandoval, et al.
The Journal of Biological Chemistry|November 26, 2005
Suppression of RhoA activity by focal adhesion kinase-induced activation of p190RhoGAP: role in regulation of endothelial permeabilityMichael Holinstat, Nebojsa Knezevic, Michael Broman, et al.
Biochemistry|May 24, 2021
<i>In Vitro</i> Biosynthetic Pathway Investigations of Neuroprotectin D1 (NPD1) and Protectin DX (PDX) by Human 12-Lipoxygenase, 15-Lipoxygenase-1, and 15-Lipoxygenase-2Wan-Chen Tsai, Chakrapani Kalyanaraman, Adriana Yamaguchi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 4, 2014
Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axisBenjamin E Tourdot, Stanley Conaway, Katrin Niisuke, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 28, 2021
Slounase, a Batroxobin Containing Activated Factor X Effectively Enhances Hemostatic Clot Formation and Reducing Bleeding in Hypocoagulant Conditions in MiceReheman Adili, Madeline Jackson, Livia Stanger, et al.
Pageof 11